United States · Funded startup

Who invested in Biolex Therapeutics

9 rounds we have observed, with the 21 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$197Mraised across 9 rounds since 2003, from 9 sources

$24MVenture$8.0MVenture$36MSeries B$30MSeries C$60MSeries D$10MDebt$20MSeries D$5.9MDebt$2.4MDebt
Latest round
Debt, $2.4MDec 2011
Biggest round
$60MSeries D · Oct 2008
Investors
21
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2005200720092011
$24MVenture$8.0MVenture$36MSeries B$30MSeries C$60MSeries D$10MDebt$20MSeries D$5.9MDebt$2.4MDebt
First round
Venture, $24M
Aug 2003
Biggest round
$60M
Series D · Oct 2008
Usual gap between rounds
16 months
the median of 8

The rounds

  1. Dec 2011
    Debt$2.4M

    No investor was named in the report.

    Reported by sec.govSEC filing: $2.4M sold, first sale Dec 2011

  2. Jun 2011
    Debt$5.9M

    No investor was named in the report.

    Reported by sec.govSEC filing: $5.9M sold, first sale May 2011

  3. Oct 2010
    Series D$20M

    No investor was named in the report.

    Reported by fis.dowjones.comSEC filing: $8.7M sold, first sale Jul 2010

  4. Feb 2010
    Debt$10M

    No investor was named in the report.

    From a historical funding recordSEC filing: $10M sold, first sale Feb 2010

  5. Oct 2008
  6. May 2007
  7. Sept 2005
  8. Jan 2005
    Venture$8.0M1 returning

    From a historical funding record

  9. Aug 2003

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Intersouth PartnersVC firm4rounds
Quaker PartnersVC firm4rounds
Mitsui VenturesGrowth equity3rounds
Polaris PartnersVC firm2rounds
Investor ABVC firm2rounds
J.P. Morgan Securities Inc.Investment bank2rounds
Dow Venture CapitalGrowth equity2rounds
Dogwood EquityInvestment firm2rounds
Kitty Hawk CapitalVC firm2rounds
OrbiMedPrivate equity1round
Clarus VenturesVC firm1round
Easton CapitalVC firm1round
Mitsui & CoCorporate VC1round
Bioventures InvestorsPrivate equity1round
Wakefield GroupVC firm1round
Tall Oaks Ventures LLCGrowth equity1round
The Dow Chemical CompanyGrowth equity1round
Franklin Street PartnersHedge fund1round
Academy Centennial Fundno record of our own yet1round
Trelys Venture Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Biolex Therapeutics

Who invested in Biolex Therapeutics?

Biolex Therapeutics's investors include Johnson & Johnson Development Corporation (JJDC), Intersouth Partners, Quaker Partners, Mitsui Ventures and Polaris Partners, and 16 more on record.

How much has Biolex Therapeutics raised?

Biolex Therapeutics has raised $197M across 9 rounds since 2003.

When did Biolex Therapeutics last raise?

Biolex Therapeutics's most recent round was a Debt of $2.4M in Dec 2011.

What was Biolex Therapeutics's biggest round?

Biolex Therapeutics's largest round on record is $60M (Series D), in Oct 2008.

Who backed Biolex Therapeutics first?

Biolex Therapeutics's first round on record, in Aug 2003, was backed by Intersouth Partners, Johnson & Johnson Development Corporation (JJDC) and Quaker Partners and 9 others.

What stage is Biolex Therapeutics at?

Biolex Therapeutics's latest named round is a Debt, in Dec 2011.

Where is Biolex Therapeutics based?

Biolex Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.